Drug Shortage Report for JAMP-GABAPENTIN
Report ID | 23888 |
Drug Identification Number | 02361469 |
Brand name | JAMP-GABAPENTIN |
Common or Proper name | Gabarentin |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-09-01 |
Estimated end date | |
Actual end date | 2017-11-23 |
Shortage status | Resolved |
Updated date | 2017-11-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-29 | English | Compare |
v2 | 2017-09-29 | English | Compare |
v3 | 2017-09-29 | French | Compare |
v4 | 2017-11-24 | English | Compare |
v5 | 2017-11-24 | French | Compare |
Showing 1 to 5 of 5